|
Pons-Fuster E, Gonzalez-Ponce CM, Ros-Martinez S, Fernandez-Avila JJ, Diaz-Carrasco MS, Espuny-Miro A. Real-world clinical outcomes of apalutamide versus abiraterone with androgen deprivation therapy for metastatic hormone-sensitive prostate cancer. Int J Clin Pharm. 2025 May 6. doi: 10.1007/s11096-025-01920-4. Online ahead of print. PubMed PMID: 40327314.
AÑO: 2025; IF: 2.6
|
40327314
|
Diaz-Carrasco MS, Sanchez-Salinas A, Fernandez-Avila JJ, Olmos-Jimenez R, Espanol-Morales I, Espuny-Miro A. Prospective observational study of oral clonazepam to prevent high-dose busulfan-induced seizures in adult patients. J Egypt Natl Canc Inst. 2025 Feb 3;37(1):4. doi: 10.1186/s43046-025-00257-3. PubMed PMID: 39894848.
AÑO: 2025
|
|
Jimenez-Pulido I, Albert-Mari MA, Conde-Estevez D, San Jose-Ruiz B, Gil-Lemus MA, Cercos-LLeti AC, Esteban-Mensua MJ, Diaz-Carrasco MS. GEDEFO-SEFH management of antineoplastic extravasations survey results. J Oncol Pharm Pract. 2024 Jan;30(1):67-77. doi: 10.1177/10781552231167873. Epub 2023 Apr 9. PubMed PMID: 37032471.
AÑO: 2024; IF: 1.0
|
|
Ramirez-Roig C, Espuny-Miro A, Olmos-Jimenez R, Diaz-Carrasco MS. Carboplatin dosing in obese patients. J Oncol Pharm Pract. 2024 Nov 4:10781552241292503. doi: 10.1177/10781552241292503. Online ahead of print. PubMed PMID: 39497478.
AÑO: 2024; IF: 1.0
|
|
Espanol I, Leal JD, Blanquer M, Garcia-Candel F, Heredia A, Gomez-Espuch J, Gonzalez C, Montserrat J, Diaz-Carrasco MS, Martinez A, Moraleda JM. N-Acetylcistein for thrombotic thrombocytopenic purpura: an observational case series study. Ann Hematol. 2023 Aug;102(8):2069-2075. doi: 10.1007/s00277-023-05248-9. Epub 2023 May 12. PubMed PMID: 37171598; PubMed Central PMCID: PMC10176284.
AÑO: 2023; IF: 3.0
|